Dolutegravir intermediate-1

Dolutegravir intermediate-1 is a synthetic intermediate of Dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV) -1 infection.

Product Specifications

CAS Number

[1335210-23-5]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

HIV

Type

Reference compound

Related Pathways

Anti-infection

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/Dolutegravir_intermediate-1.html

Purity

99.97

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(C1=C(OC)C(C(C(O)=O)=CN1CC(OC)OC)=O)OC

Molecular Formula

C13H17NO8

Molecular Weight

315.28

Precautions

H302, H315, H319, H335

References & Citations

[1]Sivaram Prasad, et al. Process for the preparation of dolutegravir . WO 2016125192 A2.

Shipping Conditions

Room Temperature

Storage Conditions

Store at room temperature, keep dry and cool

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

HIV-1

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

GTR15355560 1 Vial

Lentiviral human PABPC5 sgRNA gene knockout kit - Lentiviral human PABPC5 sgRNA gene knockout kit (100)

Ask

View Details

NBP3-08666JF646 100 µL

Mouse Monoclonal BOB1 Antibody (BOB1/2423) [Janelia Fluor 646]

Ask

View Details

GT14097 50 µg

Purified anti-human CD49b

Ask

View Details

MBS9916275 Inquire

Cavy tRNA Modification GTPase GTPBP3, Mitochondrial (GTPBP3) ELISA Kit

Ask

View Details

ABC-KD8664 1 Vial

Human LRP5 knockdown cell line

Ask

View Details